Judith Charpentier joined Astorg in 2009 and is a member of the Investment team.
She has been involved in several transactions including GRAS SAVOYE, SEBIA, LINXENS, ETHYPHARM, SGG, HRA Pharma, ECHOSENS and ERT.
Prior to joining Astorg, Judith was an Associate at Fondations Capital, a private equity fund in Paris. She started her career in 2005 with the M&A Division of Morgan Stanley in Paris, before joining the Media and Telecommunication division in New York.
Judith is an ESSEC graduate and holds a Masters in Political Science from Paris I Panthéon-Sorbonne University.